Publications
- Inhibitor of PCSK9 protein - alirocumab in clinical trials, ODYSSEY program2018 | First Faculty of Medicine
- Biologická léčba hypercholesterolemie2017 | First Faculty of Medicine
- Food supplements in dyslipidemia therapy - ArmoLIPID PLU2017 | First Faculty of Medicine
- Combination therapy of risk factors of atherosclerosis in clinical practise2017 | First Faculty of Medicine
- Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data +12015 | First Faculty of Medicine, Second Faculty of Medicine
- LDL-cholesterol: the lower the better! We need a new lipid lowering drugs? Focus on alirokumab (Praluent)2015 | First Faculty of Medicine
- Pharmacotherapy of dyslipidemia +12009 | First Faculty of Medicine
- Co s pacientem po infarktu myokardu (IM) v ambulanci praktického lékaře? Kdy potřebuje kardiologa?2023 | First Faculty of Medicine
- PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology2022 | First Faculty of Medicine
- Zahájení léčby arteriální hypertenze2022 | First Faculty of Medicine
Loading network view...